Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
“Recently approved by the U.S. Food and Drug Administration, Avandaryl is the first and only tablet to combine a thiazolidinedione [Avandia], with a sulfonylurea [Amaryl], to help improve blood sugar control,” says GlaxoSmithKline. “As an adjunct to diet and exercise, Avandaryl is indicated to improve blood sugar control in patients with type 2 diabetes who are already treated with a combination of [Avandia] and sulfonylurea, or who are not adequately controlled on a sulfonylurea alone, or for those patients who have initially responded to [Avandia] alone and require additional blood sugar control.”
Avandaryl is available in three tablet strengths: 4 mg/1 mg, 4 mg/2 mg and 4 mg/4 mg.
For more information about Avandaryl, log on to www.avandia.com or call (888) 825-5249.
Jul 1, 2006
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.